Search

Your search keyword '"Castelli Gattinara G"' showing total 113 results

Search Constraints

Start Over You searched for: Author "Castelli Gattinara G" Remove constraint Author: "Castelli Gattinara G"
113 results on '"Castelli Gattinara G"'

Search Results

1. Eligibility criteria for pediatric patients who may benefit from anti SARS-CoV-2 monoclonal antibody therapy administration: an Italian inter-society consensus statement

3. Multicentre Italian study of SARS-CoV-2 infection in children and adolescents, preliminary data as at 10 April 2020

4. Italian consensus statement on paediatric HIV infection

6. Pharmacokinetics and pharmacodynamics of nelfinavir administered twice or thrice daily to human immunodeficiency virus type 1-infected children. (HIV/AIDS Major Article)

7. Amniocentesis and chorionic villus sampling in HIV-infected pregnant women: a multicentre case series

10. Pregnancy outcomes and cytomegalovirus DNAaemia in HIV-infected pregnant women with CMV

11. A randomized controlled trial of genotypic HIV drug resistance testing in HIV-1-infected children: the PERA (PENTA 8) trial

12. Neurocognition and quality of life after reinitiating antiretroviral therapy in children randomized to planned treatment interruption

13. Duration of ruptured membranes and vertical transmission of HIV-1: a meta-analysis from 15 prospective cohort studies

14. Lamivudine/abacavir maintains virological superiority over zidovudine/lamivudine and zidovudine/abacavir beyond 5 years in children

15. Good prenatal detection rate of major birth defects in HIV-infected pregnant women in Italy

16. Antiretroviral use in Italian children with perinatal HIV infection over a 14-year period

17. Atazanavir and lopinavir profile in pregnant women with HIV: tolerability, activity and pregnancy outcomes in an observational national study

18. Using CD4 percentage and age to optimize pediatric antiretroviral therapy initiation

19. Five year follow up of vertically HIV infected children in a randomised double blind controlled trial of immediate versus deferred zidovudine: the PENTA 1 trial

20. Changing patterns of clinical events in perinatally HIV-1 infected children during the era of HAART

21. Virologic, immunologic and clinical benefits from early combined antiretroviral therapy in infants with perinatal HIV-1 infection

22. Pregnancy outcomes and cytomegalovirus DNAaemia in HIV-infected pregnant women with CMV

23. Adherence to antiretroviral therapy and its determinants in children with HIV infection: a multicentre, national study

24. Body Mass Index and Weight Gain in Pregnant Women With HIV: A National Study in Italy

25. Body Mass Index and Weight Gain in Pregnant Women With HIV: A National Study in Italy

26. The immunological and virological consequences of planned treatment interruptions in children with HIV infection

27. Birth defects in a national cohort of pregnant women with HIV infection in Italy, 2001-2011

28. Effects of nutritional rehabilitation on intestinal function and on CD4 cell number in children with HIV

29. Human immunodeficiency virus-related cancer in children: incidence and treatment outcome--report of the Italian Register

30. Rapid disease progression in HIV-1 perinatally infected children born to mothers receiving zidovudine monotherapy during pregnancy. The Italian register for HIV Infection in Children

31. Italian guidelines for antiretroviral therapy in children with human immunodeficiency virus-type 1 infection

32. Community‐acquired bacteremic pneumococcal pneumonia in children: diagnosis and serotyping by real‐time polymerase chain reaction using blood samples

33. Pharmacokinetic study of once-daily versus twice-daily abacavir and lamivudine in HIV type-1-infected children aged 3-< 36 months

34. Is the interruption of antiretroviral treatment during pregnancy an additional major risk factor for mother-to-child transmission of HIV type 1?

36. Plasma drug concentrations and virologic evaluations after stopping treatment with nonnucleoside reverse-transcriptase inhibitors in HIV type 1-infected children

39. Virologic, immunologic, and clinical benefits from early combined antiretroviral therapy in infants with perinatal HIV-1 infection

40. A randomized controlled trial of genotypic HIV drug resistance testing in HIV-infected children: the PERA (PENTA 8) trial

42. Progetto Child: la comunicazione della diagnosi al bambino sieropositivo

43. Onset of clinical signs in children with HIV-1 perinatal infection. Italian Register for HIV Infection in Children

44. A Survey on Prader-Willi Syndrome in the Italian Population: Prevalence of Historical and Clinical Signs

47. Role of immunity in maternal—infant HIV‐1 transmission

48. Serum leptin and CD4+ T lymphocytes in HIV+ children during highly active antiretroviral therapy.

49. Relationship between Changes in Thymic Emigrants and Cell-Associated HIV-1 Dna in HIV-1-Infected Children Initiating Antiretroviral Therapy

Catalog

Books, media, physical & digital resources